000 03634cam a2200433 i 4500
001 1180226403
003 OCoLC
005 20240610095240.0
008 200708s2021 pauab b 001 0 eng
015 _aGBC085345
_2bnb
020 _a9780323609623
_q$231.21
040 _cNLM
042 _apcc
050 4 _aRC801
_b.G384 2021
060 0 0 _aWI 18.2
082 0 4 _a616.3/3
_223
245 0 0 _aSleisenger and Fordtran's gastrointestinal and liver disease.
_pPathophysiology/diagnosis/management /
246 1 _aGastrointestinal and liver disease
246 1 _aPathophysiology diagnosis management
250 _a11th edition
260 _aPhiladelphia, PA
_bElsevier,
_c[2021]
264 1 _aPhiladelphia, PA
_bElsevier,
_c[2021]
300 _a(xxvi, 2215, pages) :
_billustrations (some color), maps (some color) ;
_c29 cm
504 _aIncludes bibliographical references and index
505 0 _aVolume 1. Part I. Biology of the gastrointestinal tract -- Part II. Nutrition in gastroenterology -- Part III. Symptoms, signs, and biopsychosocial issues -- Part IV. Topics involving multiple organs -- Part V. Esophagus -- Part VI. Stomach and duodenum -- Part VII. Pancreas -- Part VIII. Biliary tract
505 0 _aVolume 2. Part IX. Liver -- Part X. Small and large intestine -- Part XI. Additional treatments for patients with gastrointestinal and liver disease
520 _a"For nearly 50 years Sleisenger and Fordtran's Gastrointestinal and Liver Disease has been the go-to reference for gastroenterology and hepatology residents, fellows, physicians, and the entire GI caregiving team. Now in a fully revised 11th Edition, this two-volume masterwork brings together the knowledge and expertise of hundreds of global experts who keep you up to date with the newest techniques, technologies, and treatments for every clinical challenge you face in gastroenterology and hepatology. A logical organization, more than 1,100 full-color illustrations, and easy-to-use algorithms ensure that you'll quickly and easily find the information you need. Key features include : features new and expanded discussions of chronic hepatitis B and C, Helicobacter pylori infection, colorectal cancer prevention through screening and surveillance, biologic agents and novel small molecules to treat and prevent recurrences of inflammatory bowel disease (IBD), gastrointestinal immune and autoimmune diseases, and more ; offers reliable coverage of key topics such as Barrett esophagus, gut microbiome, enteric microbiota and probiotics, fecal microbiota transplantation, and hepatic, pancreatic, and small bowel transplantation ; provides more quick-reference algorithms that summarize clinical decision making and practical approaches to patient management ; employs a consistent, templated, format throughout for quick retrieval of information."--adapted from back cover
650 0 _aGastrointestinal system
_xDiseases
650 0 _aLiver
_xDiseases
650 1 2 _aGastrointestinal Diseases
650 2 2 _aLiver Diseases
655 2 _aExamination Questions
700 1 _aFeldman, Mark,
_d1947-2024,
_eeditor.
_1https://id.oclc.org/worldcat/entity/E39PCjMy3qwcrGxVtW6fqhWGpd
700 1 _aFriedman, Lawrence S.
_q(Lawrence Samuel),
_d1953-
_eeditor.
_1https://id.oclc.org/worldcat/entity/E39PCjxWJkR9jWdjphKTmT3jP3
700 1 _aBrandt, Lawrence J.,
_eeditor
776 0 8 _iOnline version:
_tSleisenger and Fordtran's gastrointestinal and liver disease.
_dPhiladelphia, PA :
_bElsevier,
_c[2021]
_z9780323710947
_w(OCoLC)1159444603
776 0 8 _iebook version :
_z9780323710947
942 _2lcc
_cBK
_eEleventh edition
_h801
_iGAS
_kRC
_n0
999 _c18971
_d18971